A Study on skin improving effects of a pseudo-ceramide containing formulatio
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000035170
- Lead Sponsor
- Kao Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 60
Not provided
1.Subjects who has abnormalities in the skin of the measurement regions 2.Subjects who regularly goes to hospital. 3.Subjects with the anamnesis of an alcohol or a drug dependence. 4.Subjects who regularly use drugs (hypnotic drug, anti-allergic drug, analgetic drug, hormonal drug, laxative, antiflatulent etc...). 5.Subjects who has possibilities for emerging allergy to cosmetics and/or foods (including experiences of skin irritation by cosmetics within a year). 6.Subjects who has allergy to adhesive tape and/or medical tape. 7.Subjects who suffers pollen allergy, severe rhinitis and atopic dermatitis. 8.Subjects who is pregnant or lactating, or planned to become pregnant during a test period. 9.Subjects who participates in the other clinical studies within 4 weeks in the past, or person who scheduled to participate in other clinical studies during the test period. 10.Subjects who is judged as unsuitable for the study by the investigator for other reasons. 11.Subjects who herself and/or her family members are working for the cosmetics company, the food company, an advertising agency, investigation and consultant business, and a mass media-related company. 12.Person who experienced medical cosmetic treatments (i.e. cosmetic surgery, collagen injection etc..)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the transepidermal water loss,after treatments for 4 weeks use with the pseudo-ceramide containing formulation
- Secondary Outcome Measures
Name Time Method Evaluation of the stratum corneum water content,transepidermal water loss,sebum secretion,skin color,skin viscoelasticity,stratum corneum,dermatological assessment,a questionnaire survey and VAS after treatments for 4 weeks use with the pseudo-ceramide containing formulation